
Viasan Health offers PROSANTIS, a tool for early disease detection and longevity risk assessment. It uses proteomics and machine learning to generate longevity risk scores that indicate potential onset of conditions such as CKD, heart failure, COPD, and Alzheimer’s Dementia. The product is aimed at healthcare providers and the healthcare ecosystem, operating as a B2B service in the health tech space. Core technologies include advanced proteomics, data analytics, and ML models designed for risk stratification and early warning signals. The focus is on scaling preventive care by informing clinical decisions and guiding patients toward healthier futures.

Viasan Health offers PROSANTIS, a tool for early disease detection and longevity risk assessment. It uses proteomics and machine learning to generate longevity risk scores that indicate potential onset of conditions such as CKD, heart failure, COPD, and Alzheimer’s Dementia. The product is aimed at healthcare providers and the healthcare ecosystem, operating as a B2B service in the health tech space. Core technologies include advanced proteomics, data analytics, and ML models designed for risk stratification and early warning signals. The focus is on scaling preventive care by informing clinical decisions and guiding patients toward healthier futures.